Dr. Francois J. Geoffroy, MD

Dr. Geoffroy practices at Oncology-Hematology Associates of Central Illinois P C in Peoria, Illinois.

Dr. Geoffroy's NPI, 1871593434, was assigned on July 26, 2005. Dr. Geoffroy graduated from Tufts University School of Medicine in 1984. Dr. Geoffroy holds Illinois license 036-088297.

Dr. Geoffroy's primary practice is Oncology-Hematology Associates of Central Illinois P C, at 8940 N Wood Sage Rd, Peoria, IL 61615 in Peoria County. The practice phone is (309) 243-3000.

Dr. Geoffroy's primary practice is Oncology-Hematology Associates of Central Illinois P C in Peoria, Illinois. Dr. Geoffroy is also affiliated with OSF Saint Francis Medical Center. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Geoffroy to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geoffroy practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Geoffroy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Geoffroy is licensed in Illinois.

CMS data shows 373 Medicare services from Dr. Geoffroy across 7 procedure codes in 2024, for 42 Medicare patients. Medicare paid $8,606 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Geoffroy in 2024. The largest group is 65 to 74, with 20 patients. 67% of them have high blood pressure, and 60% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Geoffroy's median patient age at 62, with 47% women.

In 2024, Dr. Geoffroy wrote 142 Medicare Part D claims for 31 patients. 87% of them were for generic drugs. CMS names the drug for 69 of them, across 3 drugs with 11 or more claims each, at $898 in total drug cost. In 2022, CMS named 284 claims across 16 drugs.

Dr. Geoffroy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Geoffroy as offering telehealth.

Dmand AI links 6 papers to Dr. Geoffroy, published from 2011 to 2024. The most frequent topics are Brain Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Glioblastoma. Dr. Geoffroy has published most often in CNS Oncol. Dr. Geoffroy's most frequent co-authors are Steven R. Abram, MD, Robert Dennis Aiken, MD and David E. Avigan, MD.

Dmand AI links Dr. Geoffroy to 2 clinical trials. Conditions studied include Adenocarcinoma Of Esophagus, Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 45 general payments to Dr. Geoffroy from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Merck Sharp & Dohme Corporation paid the most, $324.

Dr. Geoffroy graduated from Tufts University School of Medicine in 1984.